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Arboviruses are a cause of acute febrile illness and outbreaks worldwide. Recent outbreaks
of Chikungunya virus (CHIKV) in dengue endemic areas have alarmed clinicians as unique
clinical features differentiating CHIKV from Dengue virus (DENV) are limited. This has com-
plicated diagnostic efforts especially in resource limited countries where lab testing is not
easily available. Therefore, it is essential to analyse and compare clinical features of labora-
tory confirmed cases to assist clinicians in suspecting possible CHIKV infection at time of
clinical presentation.
Methodology
A prospective point prevalence study was conducted, with the hypothesis that not all
patients presenting with clinical suspicion of dengue infections at local hospitals are suffer-
ing from dengue and that other arboviruses such as Chikungunya, West Nile viruses, Japa-
nese Encephalitis virus and Zika virus are co-circulating in the Sindh region of Pakistan.
Out-patients and hospitalized (in-patients) of selected district hospitals in different parts
of Sindh province of Pakistan were recruited. Patients with presumptive dengue like
illness (Syndromic diagnosis) by the treating physicians were enrolled between 2015 and
2017.
Current study is a subset of larger study mentioned above. Here-in we compared labora-
tory confirmed cases of CHIKV and DENV to assess clinical features and laboratory findings
that may help differentiate CHIKV from DENV infection at the time of clinical presentation.
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Results
Ninety-eight (n = 98) cases tested positive for CHIKV, by IgM and PCR and these were
selected for comparative analysis with DENV confirmed cases (n = 171). On multivariable
analysis, presence of musculoskeletal [OR = 2.5 (95% CI:1.6–4.0)] and neurological symp-
toms [OR = 4.4 (95% CI:1.9–10.2)], and thrombocytosis [OR = 2.2 (95% CI:1.1–4.0)] were
associated with CHIKV infection, while atypical lymphocytes [OR = 8.3 (95% CI:4.2–16.7)]
and thrombocytopenia [OR = 8.1 (95% CI:1.7–38.8)] were associated with DENV cases at
time of presentation. These findings may help clinicians in differentiating CHIKV from DENV
infection.
Conclusion
CHIKV is an important cause of illness amongst patients presenting with acute febrile illness
in Sindh region of Pakistan. Arthralgia and encephalitis at time of presentation among
patients with dengue-like illness should prompt suspicion of CHIKV infection, and laboratory
confirmation must be sought.
Author summary
Chikungunya and Dengue viral infection are prevalent in South Asia. These are spread by
mosquito bites and present as acute febrile illness with clinical presentation difficult to dif-
ferentiate. In this study we analysed clinical findings of patients with lab confirmed Den-
gue virus and Chikungunya virus infection and compared the clinical symptoms to assess
significant features that can differentiate the two infections at time of presentation to clin-
ics and hospitals. The study was conducted at the Aga Khan University Hospital, Karachi
Pakistan. Our study confirms presence of Chikungunya virus as an etiologic agent of fever
among patients with dengue like illness in Sindh province of Pakistan. Presence of joint
pains, central nervous symptoms were more common in CHKV patients, while gastroin-
testinal symptoms and elevated liver enzymes were more commonly associated with den-
gue patients. Both viruses are endemic in Pakistan and clinical and lab diagnosis is
essential.
Introduction
Arbovirus infections are a disease spectrum associated with significant morbidity in humans.
Amongst these, Dengue virus (DENV) and Chikungunya virus (CHIKV) share geographic
and vector related features and mainly affect the tropics [1]. These vector-borne illnesses
spread by the mosquitos of the Aedes family. While DENV belongs to the genus Flavivirus,
CHIKV is a member of the genus Alphavirus in the family Togaviridae.
Both viral infections share similar disease manifestations including fever, rash and other
non-specific findings. CHIKV presents after an incubation period of 2–3 days, as an abrupt
onset of febrile illness with arthralgia and rash that resolves spontaneously in 7–10 days. How-
ever, in some patients, disease may progress to recurrent, debilitating polyarthralgia and poly-
arthritis lasting for months to years [2]. Additionally, some patients may present with signs of
central nervous system involvement, making it essential to diagnose.
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First recorded in Tanzania during 1952–53, CHIKV has caused multiple outbreaks world-
wide involving all continents but Antarctica [3]. CHIKV has been circulating actively in the
Indian subcontinent for the last decade with reports of epidemic outbreaks from India to Sri
Lanka. India reported around 1.4 million CHIKV infections in 2006 [4].
Despite this active transmission in the region, reports of CHIKV activity have been reported
from Pakistan only very recently [3–5] with the first outbreak reported from Karachi in 2017
[6–9]. The true burden of this virus in the community is largely unknown especially in the
backdrop of reports that 20–30% of clinically diagnosed DENV cases being negative for the
virus; referred to in this study as non-DENV acute febrile illness (NDFI) [10–11]. Thus possi-
bility of CHIKV infection misdiagnosed as dengue like illness.
In this study, we analysed subset of data of an active surveillance study for patients with
acute febrile illness and/or suspected DENV infection in 5 cities of Sindh province in Pakistan.
This study aimed firstly to ascertain the presence of CHIKV as etiologic agent of NDFI in
Sindh province, and secondly, to compare clinical features of laboratory confirmed CHIKV
cases with DENV infection to identify clinical features and laboratory findings that may help
differentiate CHIKV from DENV infection at the time of clinical presentation.
Methods
Ethics statement
This study was approved by Institutional Review Board of the Aga Khan University Hospital
(reference number 3183-PAT-ERC-14). Informed consent was obtained from all adult patients
enrolled. The process of sample collection and questionnaire was explained to the children
and adolescent patients in simple words. If they agreed, informed consent was taken from
their parent(s)/ guardian(s).
A prospective, cross-sectional study was carried out to assess role of arboviruses namely:
Chikungunya, West Nile and Japanese encephalitis virus as cause of fever in NDFI cases in the
Sindh region of Pakistan from 2015–2017. Surveillance for febrile illness was conducted at five
major cities: Karachi, Hyderabad, Sukkhar, Larkana and Mirpurkhas. The combined popula-
tion of these cities is over 25.3 million and consists of a mix of urban, peri-urban and rural set-
tings. For this comparative study, a subgroup analysis was performed on patients who tested
positive for DENV and CHIKV.
Patient selection and data collection
We recruited patients from 5 district hospitals one in each city. Patients presenting with acute
febrile illness to out -patient department (OPD patients) and those admitted with dengue like
illness (see details below) were recruited over a period of 3 years from 2015–2017. Appointed
medical officers at each field site enrolled patients after taking written consent in accordance
with the Declaration of Helsinki. In case of children less than 18 years, consent was sought
from parents after the patients gave verbal assent to participation and sampling. Consent was
taken in local language. Inclusion criteria was patients between 10–60 years of age with a fever
>over 38oC (>100.4oF) for 3–10 days, with either of the following symptoms: headache,
myalgia, arthralgia, vomiting, macular/ petechial rash, bleeding diathesis, altered mental status,
or acute flaccid paralysis. Since the other causes of acute febrile illness had to be ruled out, i.e.
typhoid by blood culture, malaria parasite by blood film and CBC to assist clinicians in patient
management, in addition to serum collected for the viral studies. Consequently a large volume
of blood sample (25 ml) was required, and this was the main reason for not including very
young and very old patients. Thus, the exclusion criteria were age less than 10 years and>60
years, presence of chronic liver disease, haematological malignancies or chronic illnesses
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requiring use of steroids (>20mg/day of prednisolone for> 2 weeks, or other immunosup-
pressant). Non-probability consecutive sampling was used. Samples were de-identified and
stored at -80˚C after separation of serum. DENV and CHIKV testing was performed using a
commercial IgM Enzyme-Linked Immunosorbent Assay (ELISA) (CHIKjj Detect IgM, InBios
International, Inc, Seattle, WA) and reverse-transcription polymerase chain reaction
(RT-PCR). Laboratory results, along with epidemiological and clinical data were recorded in a
predefined questionnaire.
Clinical and laboratory testing
Clinical diagnosis and patient management were performed according to the hospital’s stan-
dard of care. Details of the patient’s clinical and laboratory profiles were entered in the prede-
fined data collection form by a trained research medical officer. Clinical diagnosis was defined
as the provisional diagnosis made by the treating physician at the time of presentation before
the etiological diagnosis was established by the laboratory tests.
A laboratory diagnostic algorithm was followed (Fig 1). Samples that tested negative for
DENV were considered as NDFI and were then evaluated for other viruses including CHIKV
infection by IgM ELISA and RT-PCR. Hence, co-infection with dengue and chikungunya was
not evaluated.
Serologic interpretation- ELISA. CHIKV and DENV immunoglobulin M (IgM) anti-
bodies were detected via commercial IgM ELISA platforms (CHIKjj Detect IgM, InBios Inter-
national, Inc, Seattle, WA), (DENV Detect IgM, InBios International, Inc, Seattle, WA)
according to manufacturer instructions. These are sandwich-type immunoassays that detect
human antibodies targeting the CHIKV and DENV envelope glycoproteins. Any indetermi-
nate or borderline samples were retested and evaluated in duplicate to verify immune status.
Dengue IgM was tested for cross-reactivity with other flaviviruses like West Nile, Japanese
Encephalitis and Zika by Plaque Reduction Neutralization Test (PRNT). Dengue subtyping
was done by PCR for antigen positive samples and PRNT for IgM positive samples.
RT-PCR. RNA extractions were performed using the QIAamp Viral RNA Mini kit (QIA-
GEN, Hilden, Germany) and RT-PCR performed as described elsewhere [8, 10]. A cycle
threshold (Ct) value of<40 cycles was regarded as positive.
Statistical analysis
Data from proforma was double entered into EpiData database. Data was then extracted in
Microsoft Excel and transferred to SPSS 21.0 software for statistical analysis.
Frequencies and proportions were determined for qualitative variables, whereas, mean and
standard deviation was calculated for quantitative variables. Pearson’s Chi-Square test and
Independent t-test was used to identify associations between variables.
Results
991 patients with a clinical diagnosis of DENV infection were enrolled. Of these 17.25%
(n = 171) tested positive and confirmed as DENV infection. 11.95% (n = 98) of NDFI patients
tested positive for CHIKV via IgM ELISA and RT-PCR. 79.6% (n = 78) cases of CHIKV were
detected by IgM while 11.2% (n = 11/98) of samples tested positive for CHIKV by either
ELISA or RT-PCR; fulfilling the CDC diagnostic criteria [12] for a confirmed infection. For
Dengue fever, 63.1% (n = 108) of NS1Ag positive were also positive for IgM antibodies, while
DENV was detected by PCR in 45.6% (n = 78) cases.
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Patient demographics
Patients with DENV were significantly younger than patients with CHIKV infection. DENV
patients had a mean age of 33.6 years while CHIKV-infected patients had a mean age of 40.3
years (Table 1). More than 80% of patients in both groups were adults, with males comprising
56.7% and 55.10% of the population for DENV and CHIKV, respectively.
Fig 1. The diagnostic algorithm for DENV and CHIKV serologic testing. Flow chart illustrating patient recruitment
according to inclusion criteria and workflow of specimen for DENV and CHIKV detection.
https://doi.org/10.1371/journal.pntd.0008086.g001
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The majority of patients with DENV were from Karachi (87.1%, n = 149), followed by
Hyderabad (6.4%, n = 11) (Table 1). Karachi was also the site for most of the CHIKV positive
cases (91%, n = 89), then Hyderabad (5.05%, n = 5) (Table 1). Upper Sindh showed less activity
for both DENV and CHIKV infection with only 4% of DENV patients from Mirpurkhas and
1% from each Sukkhar and Larkana. For CHIKV infection, 2% of patients were enrolled from
Sukkhar and 1% each from Mirpurkhas and Larkana.
Clinical findings
Symptoms. Most patients presented with a fever of less than 7 days with mean duration of
4.2 days in patients with DENV infection as compared to 5.4 days in patients with CHIKV
infection.
Average fever of patients with CHIKV was 100.5˚F and patients with DENV had an average
temperature of 100.3˚F. While there were differences in average systolic blood pressure, respi-
rations and pulse, these variables were not statistically significant.
While Glasgow Coma Scale (GCS) did not differ significantly between the 2 groups,
patients with confirmed CHIKV infection frequently presented with severe musculoskeletal
pain and central nervous system (CNS) related symptoms (such as altered mentation, confu-
sion and loss of consciousness): this difference was statistically significant with a p-value of
0.001. Gastrointestinal (GI) symptoms including nausea, abdominal pain and vomiting were
reported in 53.8% of DENV patients (p<0.001) (Table 2). Haemorrhage was significantly
associated with DENV virus infection with 8% of patients presenting with this symptom
(p = 0.040) (Table 2). Rash was seen in 15.3% and 15.2% of CHIKV and DENV cases respec-
tively and was not a significant predictor of disease (Table 2).
Laboratory tests
Haematological tests. Average haematocrit and haemoglobin levels were within normal
range for both DENV and CHIKV patients though 34.1% of DENV patients exhibited elevated
haematocrit p<0.001 (as compared to 20% of CHIKV patients). For DENV, thrombocytope-
nia (defined as platelet count <150,000/mm3). was a significant predictor of disease with
Table 1. Demographics of patients diagnosed with either DENV or CHIKV. Bold font indicates statistical significance.
CHIKV DENV
Continuous variable Mean ±SD Mean ±SD Difference (95%CI)
Mean age [years] 40.2 ±17.1 33.6 ±15.1 6.6 (2.5 to 10.7)
Categorical variables n = 98 (%) n = 171 (%) OR (95%CI)
Children 10 (10.2) 22 (12.9) 0.8 (0.3–1.7)
Adults 88 (89.8) 149 (87.1) 1.2 (0.6–1.9)
Male 54 (55.1) 97 (56.7) 1.0 (0.8–1.2)
Female 44 (44.9) 74 (43.2) 1.1 (0.8–1.4)
Location (total recruited)
Karachi 89 (90.8) 149 (87.1) -
Mirpurkhas 1 (1.0) 7 (4.1) -
Sukkhar 2(2.0) 2 (1.2) -
Larkana 1(1.0) 2 (1.2) -
Hyderabad 5 (5.1) 11(6.4) -
Demographics of patients with dengue and Chikungunya virus infections. Qualitative variable is represented with frequency count and proportion [n = (%)] whereas for
quantitative variables, mean and standard deviation [mean (SD)] is given. OR = Odds ratio, 95%CI = 95% confidence interval.
https://doi.org/10.1371/journal.pntd.0008086.t001
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74.1% of patients exhibiting this phenomenon (p<0.001) as compared to 18% of CHIKV
patients; almost 150 platelets less than CHIKV (Table 2). While both DENV and CHIKV
infected patients exhibited, on average, elevated leucocyte counts, 87% of DENV infected
patients presented with atypical lymphocytes and were 3 times more likely to present with this
sign than patients infected with CHIKV (Table 2). Altered red blood cell (RBC) morphology
was also a significant finding and was reported almost twice as frequently in CHIKV infected
patients than DENV infected patients, with 36.7% of CHIKV patients showing elevate levels of
misshaped RBCs compared to only 20% of DENV patients (Table 2).
Liver function tests. Upon enrolment, the mean alanine aminotransferase (ALT) and
mean aspartate aminotransferase (AST) levels of patients with CHIKV were within the normal
range (55.13 IU/L and 60.90 IU/L, respectively) while DENV patients had significantly higher
mean levels of ALT (113.4 IU/L) and AST (158.7 IU/L) (Table 2).
Patients with DENV were more likely to have elevated liver enzymes, 88.4% AST (OR 3.6,
95% CI: 1.2–10.7) and 58.3% ALT (OR 2.6, 95% CI: 1.2–5.6) than patients with CHIKV (68.1%
AST and 35.1% ALT).
Multivariable analysis. On multivariable analysis (not shown in tables), presence of mus-
culoskeletal [OR = 2.5 (95% CI:1.6–4.0)] and neurological symptoms [OR = 4.4 (95% CI:1.9–
Table 2. Clinical presentation and laboratory findings of acute febrile patients with Dengue virus and Chikungunya virus infection from Sindh, Pakistan 2015–
2017 (Bold font indicates statistical significance).
CHIKV DENV Difference (95%CI) OR CHIKV (95%CI) OR DENV (95%CI)
Clinical presentation Mean ±SD Mean ±SD
Mean days of fever 5.4±5.4 4.2±1.9 1.2 (0.1 to 2.4) - -
Mean temperature˚C 100.5±2.0 100.2±1.9 0.2(-0.3 to 0.8) - -
Pulse (beats per minute) 97.2±16.2 95±19.7 2.3(-3.0 to 7.6) - -
Respirations (breaths per minute) 21.2±4.3 21±6.9 0.1(-1.6 to 1.9) - -
Mean systolic pressure 121±23.0 115.7±15.4 5.3 (-0.7 to 11.3) - -
Mean GCS 14.2±2.4 14.9±0.9 -0.7 (-1.2 to -0.2) - -
Symptoms n (%) n (%)
Gastrointestinal 26 (26.5) 92 (53.8) - 0.5 (0.3 to 0.7) 2.0(1.4 to 3.0)
Respiratory 2 (2.0) 2 (1.2) - 1.7 (0.2 to 12.1) 0.6 (0.1 to 4.0)
Neurological 21(21.4) 12 (7.0) - 3.0 (1.6 to 5.9) 0.3(0.2 to 0.6)
Haemorrhage 2 (2.0) 14 (8.1) - 0.2 (0.1 to 1.1) 4.0 (0.9 to 17.3)
Musculoskeletal 61 (62.2) 51 (29.8) - 2.1 (1.6 to 2.7) 0.5(0.4 to 0.6)
Ocular 9 (9.2) 11 (6.4) - 1.4 (0.6 to 3.3) 0.7 (0.3 to 1.6)
Rash 15 (15.3) 26(15.2) - 1.0 (0.6 to 1.8) 1.0 (0.5 to 1.8)
Laboratory parameters Mean ±SD Mean ±SD
Aspartate aminotransferase (IU/L) 60.9±30.1 158.8±137.1 -97.9 (-125.5 to—67.2) - -
Alanine aminotransferase (IU/L) 55.1±53.3 113.4±115 -58.2 (-85.4 to—31.2) - -
Haemoglobin (g/dl) 12.1±2.5 13.6±2.0 -1.5 (-2.1 to -0.9) - -
Haematocrit (%) 37.2±6.6 40.5±5.6 -3.4 (-5.0to-1.7 - -
Total leucocyte count (x109/l) 8.6±4.7 4.2±2.3 4.5 (3.4 to 5.4) - -
Platelets (x109/l) 254.7±150.1 110.8±89.8 143.5 (109.8 to 177.1) - -
Altered red blood cell morphology seen 36 (36.7) 35 (20.5) - 1.8 (1.2 to 2.7) 0.6 (0.4 to 0.8)
Atypical lymphocytes seen 28 (28.6) 149(87.1) - 0.3 (0.2 to 0.5) 3.0 (2.2 to 4.2)
Comparison of clinical presentation and laboratory profile amongst patients with dengue and Chikungunya virus infections. Qualitative variable is represented with
frequency count and proportion [n = (%)] whereas for quantitative variables, mean and standard deviation [mean (SD)] is given. GCS = Glasgow Coma Scale,
OR = Odds ratio, 95%CI = 95% confidence interval.
https://doi.org/10.1371/journal.pntd.0008086.t002
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10.2)], and thrombocytosis [OR = 2.2 (95% CI:1.1–4.0)] were associated with CHIKV infec-
tion, while atypical lymphocytes [OR = 8.3 (95% CI:4.2–16.7)] and thrombocytopenia
[OR = 8.1 (95% CI:1.7–38.8)] were associated with DENV cases at the time of presentation.
Clinical management. At presentation, 83.0% of DENV patients were clinically diag-
nosed with a viral infection, while only 50% of patients in the CHIKV group were diagnosed
with a viral infection (Table 3). 10.2% of CHIKV patients were diagnosed with a bacterial
infection and 12% as having a non-infectious aetiology by physicians (Table 3). Malaria was
suspected in 10% of DENV infected patients and 6% of CHIKV patients (Table 3).
Despite have fewer viral diagnoses, CHIKV infected patients were 4 times more likely to
receive antiviral therapy (primarily acyclovir) than DENV patients (Table 3). While not signifi-
cant, use of steroid therapy was documented in 5.1% of CHIKV patients as compared to 3.5%
of patients with DENV (Table 3). Fluid replacement therapy was required in 76.6% of DENV
patients and 51% of CHIKV infected patients (Table 3). Up to 60% of patients required analge-
sics in both groups (Table 3).
Discussion
In this study, we show that CHIKV is an important cause of NDFI cases in the Sindh province
(12.1%) cases. These values are in contrast to those reported from other countries in the Asian
region. Reller et al from Sri Lanka, in 2015 reported acute CHIKV infection in 3.5% of patients
with acute febrile illness, 82.7% remained undiagnosed after complete laboratory workup [10].
Similarly, studies from India have reported CHIKV prevalence of 9.6–25% while 37%
remained undiagnosed [6,11]. In our study most cases were from Karachi; one of the most
densely populated cities in the world with a variety of social/economic factors contributing to
uncontrolled urbanization and poor sanitation standards. This study also included samples
from cluster outbreak of CHIKV infection during November 2016 that made the headline
news in the country with 30,000 patients suspected of CHIKV infection [9].
Table 3. Clinical diagnosis and management profile with outcomes of patients suffering from acute Chikungunya and Dengue enrolled from Sindh, Pakistan
[2015–2017].
Provisional diagnosis Chikungunya n = 98(%) Dengue n = 171(%) OR for CHIKV (95%CI) OR for DENV (95%CI)
Viral infection 49 (50) 142 (83.0) 0.6 (0.5 to 0.7) 1.7 (1.3 to 2.0)
Bacterial infection 10 (10.2) 12 (7.0) 1.5 (0.7 to 3.2) 0.7 (.3 to 1.5)
Malaria 6 (6.1) 17 (9.9) 0.6 (0.3 to 1.5) 1.6 (0.7 to 4.0)
Suspected non-infectious aetiology 12 (12.2) 12 (7.0) 1.7 (0.8 to 3.7) 0.6 (0.3 to 1.2)
Therapy
Antiviral agent 10 (1.02) 4 (2.3) 4.3 (1.4 to 13.4) 0.2 (0.1 to 0.7)
Systemic steroids 5 (5.1) 6(3.5) 1.5 (0.5 to 4.7) 0.7 (0.2 to 2.2)
Fluid replacement 50 (51.0) 131 (76.6) 0.6 (0.5 to 0.8) 1.5 (1.2 to 1.8)
Transfusions 1 (1.0) 4 (2.3) 0.4 (0.1 to 3.8) 2.3 (0.3 to 20.2)
Anti-malarial 1 (1.0) 3 (1.7) 0.6 (0.1 to 5.5) 1.7 (0.2 to 16.3)
Analgesics 59 (60.2) 106 (61.9) 1.0 (0.8 to 1.2) 1.0 (0.8 to 1.3)
Alive 92/92 (100) 170/170 - -
Difference (95%CI)
Mean length of hospital stay (days) 3.1±5.2 3.5±2.6 -0.3 (-1.5 to 0.8)
Clinical diagnosis and management profile amongst patients with dengue and Chikungunya virus infections. Qualitative variable is represented with frequency count
and proportion [n = (%)] whereas for quantitative variables, mean and standard deviation [mean (SD)] is given. OR = Odds ratio, 95%CI = 95% confidence interval.
https://doi.org/10.1371/journal.pntd.0008086.t003
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Co-circulation of DENV and CHIKV in Karachi reflects a progressive deterioration of
municipal infra-structure and efforts to control mosquitos [13]. More concerning is the identi-
fication of DENV and CHIKV in less densely populated peri-urban and rural areas, which lack
of basic public health facilities, piped water and municipal infrastructure, making future epi-
demics imminent as seen in neighbouring India [14], unless preventive strategies are imple-
mented in a timely manner.
Clinically, longer duration of fever, severe arthralgia and neurological manifestations were
significantly associated with CHIKV. Twenty-one percent of CHIKV positive patients pre-
sented with CNS manifestations. This may have prompted the use of acyclovir in management
of patients with CHIKV infection at time of admission, in lieu of possible herpes encephalitis.
Similar findings of CNS involvement at time of presentation have been reported from India
where altered mental status was seen in 56.67% of CHIKV patients requiring admission to
intensive care units [15]. Literature from most of the CHIKV endemic region (i.e. Indian
Ocean, South Asia, the Pacific islands, Southern Europe, the Caribbean, and South America)
have reported neurological manifestation of CHIKV [16].
A study in La Reunion reported 24.1% of CHIKV cases presenting with abnormal neuro-
logical signs and symptoms [17]. And a recent study from Pakistan reported neurological
symptoms in almost half of patients with confirmed CHIKV infections [8].
GI manifestations were most pronounced in patients with DENV infection, with 53.8% of
DENV cases as compared to 26.2% of CHIKV, a finding that may help differentiate the two
infections in clinical setting. The association of DENV with GI symptoms has consistently
been reported from other endemic regions. Ramos et al in their retrospective review of 8559
patients reported GI symptoms in 67% of DENV patients [18]. In vitro studies have also
shown DENV to have a predilection for GI tissue, especially liver [19]. This may explain the
elevated AST and ALT levels in the DENV group and other reports from endemic regions
[20]. Fernando et al recommend testing for liver function enzymes after 4–5 days of illness, as
low levels of liver enzymes at the early stage of disease may underestimate ongoing liver dam-
age [21]. Similarly, a study from Bangkok estimated up to a ten-fold increase of ALT/AST
from baseline in hepatitis associated with severe DENV cases [22].
These findings are significant for Pakistan as chronic hepatitis B and C along with other
gastrointestinal infections are endemic in the population. This data should alert physicians to
include DENV in the differential diagnosis of patients presenting with fever, hepatitis and
acute gastrointestinal symptoms.
Pronounced musculoskeletal symptoms including polyarthralgia was reported in 62.2% of
CHIKV patients as compared to 29.8% in DENV patients. These symptoms may have resulted
in misdiagnosis of CHIKV infection as non-infectious arthritis by clinicians at time of presen-
tation and resultant use of steroids in these patients.
No significant difference was seen in the frequency of rash in both groups. The presence of
comparatively lower systolic pressures in DEN-V and increased levels of haematocrit likely
reflect plasma leakage resulting from increased vascular permeability and third spacing. [18].
Fluid replacement and supportive management was required more frequently in DEN-V
patients, a finding in concordance with other reports from Pakistan [23, 24] and other parts of
dengue endemic region [1,25].
Higher leucocyte counts and atypical lymphocytes were observed for DENV. Significant
thrombocytopenia was also found in DENV patients. This corroborates the findings of Lee
et al in their study on CHIKV versus DENV infections in adults [1]. While case fatality has
been associated with both DENV and CHIKV, all patients in our study survived, [15, 26–29].
For laboratory diagnostics, the Dengue Early Rapid NS-1 test was the most effective for
DENV detection as most cases of DENV infection were detected using this assay. Many of
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these patients were also positive by RT-PCR. Most NS-1 negative cases in our study were also
negative by RT-PCR, validating the clinical utility of the NS-1 assay. While factors such as
specimen shipping and delayed preservation could be possible reasons for the false negative
RT-PCR cases in our study population, our findings agree with Ahmed et al who found that
the overall performance of DENV RT-PCR to be no better than NS-1 antigen detection [30].
For the CHIKV serological diagnosis, 11% were positive with both IgM ELISA and
RT-PCR, while 31.3% were detected only by RT-PCR, indicating that use of IgM alone in clini-
cal settings as diagnostic assay may be insufficient and may result in false negative cases. This
may happen in early phase of disease when antibodies are not detectable due to neutralization
with viral antigen.
Nucleotide sequencing reports have shown associations of specific mutations at residue 226
of membrane fusion glycoprotein E1 (E1-A226V) region with disease severity and better virus
adaptability [31]. These mutations have been associated with abrupt epidemic outbreaks of
CHIKV. A study from La Reunion reported 34.3% of the total island population infected with
viral containing the E1-A226V mutation [31]. Whole genome sequencing studies are currently
underway to identify any mutations in CHIKV isolates yielded from Pakistan.
Most of our CHIKV patients were adult males which is in concordance with CHIKV epi-
demic reports from India and other regions [32, 33]. One sero-survey conducted in Calcutta
reported the highest infection rate adults aged 50–55 years and virtually no sero-positivity in
young children [34]. Further studies are required to explore this apparent age predilection in
our population especially in very young children as this group was not included in this study.
Our study is limited by the nested design on a cross-sectional surveillance of febrile patients
who presented to health centres. Since there was no follow-up, the outcomes and long-term
sequelae of CHIKV infections could not be assessed. Disease severity data was also not col-
lected; hence the subgroup of severe dengue cases could not be compared with CHIKV cases
admitted to the hospital. Another shortcoming was the testing algorithm: as only DENV NS1
negative cases were tested for CHIKV, co-infections and specific manifestations in such cases
could not be determined.
Conclusion
Our study confirms that CHIKV is present in Sindh region of Pakistan and is an important
cause of acute febrile illness. Patients with CHIKV infection are more likely to present with
severe arthralgia and neurological symptoms. The recent CHIKV outbreak in Karachi high-
lights the possibility of Karachi having an epidemic potential in future, unless timely preven-
tive interventions are ensured. While the sample size and the study design was insufficient
to calculate the actual prevalence of disease in the community, our findings raise concerns for
the possible circulation of a virulent CHIKV genotype known for its high rate of CNS
involvement.
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